Fast-acting psychedelic DMT eases depression in first clinical trial
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
A clinical trial has found that the fast-acting psychedelic DMT may ease depression. The trial's results suggest that a single dose of DMT can rapidly reduce symptoms of major depressive disorder, although it is unclear how its effectiveness compares to existing treatments. The potential of short-acting psychedelics like DMT to treat depression is being explored, with some studies also investigating its benefits and challenges in comparison to other treatments.
Full coverage
12345678